This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Treatment by Lara Lewis McGrath
Introduction
Lara Lewis McGrath is an accomplished inventor based in Arlington, VA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for treating cancer, showcasing her dedication to advancing medical science.
Latest Patents
Lara holds a patent for "Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)." This patent includes various embodiments relating to antibodies and fusion proteins that bind CCR8. These antibodies and fusion proteins have potential applications in methods to treat cancer, highlighting their importance in therapeutic development.
Career Highlights
Lara is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. Her role at Gilead allows her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Lara collaborates with talented professionals in her field, including Fabien Dépis and Changyun Hu. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Lara Lewis McGrath's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her contributions through patents and collaborations are paving the way for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile